Sorted By:

Relevance


Quality Measures Addressing Cancer Care

PhRMA  |  Fact Sheet

Value in healthcare is commonly defined as the health outcomes achieved per dollar spent.
https://www.phrma.org

Burden on Patients: Limiting Access to Necessary Medicines Threatens Hope for Oncology Patients

PhRMA  |  Blog Post

fact sheets and state-by-state information on what the exchanges mean for patients suffering from various chronic conditions.
http://catalyst.phrma.org/burden-on-patients-limiting-access-to-necessary-medicines-threatens-hope-for-oncology-patients

Significant progress fighting cancer: Death rate has dropped 25 percent

PhRMA  |  Blog Post

In the last decade, we’ve seen a number of scientific advances transform the landscape of many cancers.
http://catalyst.phrma.org/significant-progress-fighting-cancer-death-rate-has-dropped-25

PhRMA letter to Puerto Rico Secretary of Economic Development and Commerce

PhRMA  |  Press Release

This determination is based on the contingency planning that our member companies have undertaken, the ability of our member companies to shift production to other manufacturing locations and the reserve supplies of medicines they maintain.
https://www.phrma.org/press-release/phrma-letter-to-puerto-rico-secretary-of-economic-development-and-commerce

ICYMI: New Study Highlights Often High Out-of-Pocket Costs in Exchanges

PhRMA  |  Blog Post

Earlier this week, the Kaiser Family Foundation released new research about the deductibles in different health insurance exchange plans.
http://catalyst.phrma.org/icymi-new-study-highlights-often-high-out-of-pocket-costs-in-exchanges

PhRMA Announces Support for Seven-Day Script Limit on Opioid Medicines for Acute Pain

PhRMA  |  Press Release

The public-private partnership would allow increased information sharing and collaboration between government and industry to speed the drug development process.
https://www.phrma.org/press-release/phrma-announces-support-for-seven-day-script-limit-on-opioid-medicines-for-acute-pain

In the Pipeline

PhRMA  |  From PhRMA

Biopharmaceutical research has revolutionized medical treatment decisions in the last few decades, and we're not slowing down. With over 7,000 medicines in development around the globe, patients today have more hope for a better quality of life. Find out more about the potential of the biopharmac...
https://www.phrma.org/science/in-the-pipeline

Harnessing the power of real-world evidence to benefit patients through PDUFA VI

PhRMA  |  Blog Post

You can also learn more about PDUFA VI and its key provisions by viewing our PDUFA VI fact sheet and recent blog post What you need to know about PDUFA VI.
http://catalyst.phrma.org/harnessing-the-power-of-real-world-evidence-to-benefit-patients-through-pdufa-vi

340B Spotlight: New study raises questions about whether non-profit hospitals are meeting charity care requirements in Affordable Care Act

PhRMA  |  Blog Post

Given that non-profit hospitals do not have requirements on the scope of their charity care programs (either under the 340B program or under the Affordable Care Act provision, as it allows non-profit hospitals to set their own eligibility standards for charity care), additional charity care requirements for hospitals that participate in the 340B program should be considered.
http://catalyst.phrma.org/340b-spotlight-new-study-raises-questions-about-whether-non-profit-hospitals-are-meeting-charity-care-requirements-in-affordable-care-act

Opportunities to build upon enhanced competition for medicines in the marketplace

PhRMA  |  Blog Post

In fact, after discounts and rebates, brand medicine growth increased just 3.5 percent in 2016, below projections and in line with general medical inflation.
http://catalyst.phrma.org/opportunities-to-build-upon-enhanced-competition-for-medicines-in-the-marketplace

Dilemma Over Deductibles: Costs Crippling Middle Class

Access Better Coverage  |  From Our Network

But health care researchers point to a convergence of trends building for years: the steep rise in deductibles even as premiums stabilize, corporate belt-tightening since the economic downturn and stagnant middle-class wages.
http://www.accessbettercoverage.org/social-news/dilemma-over-deductibles-costs-crippling-middle-class

Burden on Patients: Preserving the ‘New Normal’ for Patients with Rheumatoid Arthritis

PhRMA  |  Blog Post

new fact sheets on what the exchanges mean for patients suffering from chronic conditions.
http://catalyst.phrma.org/burden-on-patients-preserving-the-new-normal-for-patients-with-rheumatoid-arthritis

Burden on Patients: Two Steps Forward and One Step Back for HIV/AIDS Patients

PhRMA  |  Blog Post

fact sheets.
http://catalyst.phrma.org/burden-on-patients-two-steps-forward-and-one-step-back-for-hiv/aids-patients

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

PhRMA’s own Sharon Brigner noted she’s found a rewarding career advocating for patients at the bedside and at the policy table.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma

Burden on Patients: Access to Asthma Medicine and the Risk of Going Without

PhRMA  |  Blog Post

fact sheets.
http://catalyst.phrma.org/burden-on-patients-access-to-asthma-medicine-and-the-risk-of-going-without

340B Spotlight: ICYMI – 340B hearing, new reports highlight growing need for program reform

PhRMA  |  Blog Post

Increasing costs to patients, which is the result of this shift in site of care, directly undermines the purpose of the 340B program and its aim to help patients get access to affordable medicines.
http://catalyst.phrma.org/340b-spotlight-icymi-340b-hearing-new-reports-highlight-growing-need-for-program-reform

I'm Not Average: Loretta Survives Cancer Despite the Odds

PhRMA  |  Video

At first, she thought it was a death sentence - but in time she resolved, "I will live with this and I will live well for the rest of my life."
https://www.phrma.org/video/i-m-not-average-loretta-is-still-living-well-12-years-after-her-cancer-diagnosis

VIDEO: PhRMA CEO discusses industry response to opioid crisis on Mornings with Maria

PhRMA  |  Blog Post

The public-private partnership would allow increased information sharing and collaboration between government and industry to speed the drug development process.
http://catalyst.phrma.org/video-phrma-ceo-discusses-industry-response-to-opioid-crisis-on-mornings-with-maria

PhRMA Applauds Passage of Korea-U.S. Free Trade Agreement

PhRMA  |  Press Release

Free Trade Agreement' fact sheet.
https://www.phrma.org/press-release/phrma-applauds-passage-of-korea-u-s-free-trade-agreement

Compulsory licensing: A misused and abused international trade law

PhRMA  |  Blog Post

In fact, one obligation under international law requires that, prior to issuing a compulsory license, the acting government must first pursue a voluntary license with the patent-holder.
http://catalyst.phrma.org/compulsory-licensing-a-misused-and-abused-international-trade-law

340B Spotlight: Trends in shifting site of care

PhRMA  |  Blog Post

One way hospitals drive this site of care shift is through the purchase or acquisition of independent physician practices.
http://catalyst.phrma.org/340b-spotlight-trends-in-shifting-site-of-care

4 facts on why drug importation is bad for patients

PhRMA  |  Blog Post

It has become very easy for counterfeiters to make bottles and packages look genuine, but the reality is they are often filled with laced, adulterated or fake pills that are dangerous to patients. 
http://catalyst.phrma.org/4-facts-on-why-drug-importation-is-bad-for-patients

Access to Combination Therapies May Be Limited with Exchange Coverage

PhRMA  |  Blog Post

To learn more about health coverage and access to prescription medicines, visit PhRMA’s new resource, AccessBetterCoverage.org and check out our fact sheet on combination therapies.
http://catalyst.phrma.org/access-to-combination-therapies-may-be-limited-with-exchange-coverage

Illustrative Pharmaceutical Lifecycle

Chartpack  |  From Our Network

New medicines face competition after a relatively short period on the market.
http://chartpack.phrma.org/biophrma-chartpack/research-and-development/illustrative-pharmaceutical-lifecycle

Welcome to the new PhRMA.org

PhRMA  |  Blog Post

Browse through an expansive collection of blog posts, graphics, videos, fact sheets and reports in the Resource Library.
http://catalyst.phrma.org/welcome-to-the-new-phrma.org

You have reviewed the first 275 results out of 1198. Each page contains 25 results. You're on page 11.

prev 7 8 9 10 11 12 next